Chief operating officer Lynne Parshall said in a statement: “Our goal is to create medicines that will save patients’ lives, and we are proud to be at the forefront of creating innovative medicines. We decided to change our company name because, when people see or hear our name, we want them to think about the life-saving medicines we are developing.” The drugmaker, a $7 billion company, has been around for more than a quarter century. They have one cholesterol drug on the market and treatments in development for a plethora of diseases, including cancer and heart conditions. It took a longtime, of about one year,. for decision of the name’s change to be made.